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Abstract
Obstructive sleep apnea (OSA) represents a major public health issue affecting 
over 10% of the general adult, more than 80% of the geriatric, and up to 11% of the 
pediatric populations. Numerous studies have demonstrated distinct associations 
between OSA and diabetes, daytime drowsiness, and cardiopulmonary compromise 
including myocardial infarction. Considering the estimated rate of underdiagno-
sis, OSA is expected to exert a significant unrealized toll on the global healthcare 
infrastructure with the number of diagnoses increasing each year. The diagnosis 
of OSA entails subjective and objective evaluations including sleep surveys and 
polysomnography. Accordingly, treatment of OSA also encompasses a large variety 
of conservative, pharmacologic, and surgical interventions. Treatment selection 
remains a difficult but critical part of intervention especially when multiple modali-
ties are required. This chapter aims to describe not only the presentation of this 
head and neck airway pathology but the interprofessional management strategies 
employed.
Keywords: polysomnography, apnea, hypopnea, obstructive sleep apnea, obesity, 
continuous positive airway pressure, septoplasty, uvulopalatopharyngoplasty, 
hyoid suspension, genioglossus advancement, maxillomandibular advancement, 
hypoglossal nerve stimulation
1. Introduction
Obstructive sleep apnea (OSA) is a common disease of the head and neck respi-
ratory tract with severe systemic ramifications [1, 2]. It is characterized by multiple 
episodes of apnea or hypopnea during sleep resulting from partial and/or complete 
collapse of the upper airway [3].
OSA affects 10% or more of the population with males at increasingly greater 
risk than females [4]. It contributes to chronic conditions such as obesity, diabetes, 
myocardial infarction, and daytime drowsiness that leads to frequent motor vehicle 
accidents [3]. Many surgical and non-surgical treatment modalities exist, including 
continuous positive air pressure (CPAP) devices that keep the patency of the airway 
via exerting a baseline artificial inspiratory pressure. When patients are unable or 
unwilling to tolerate these bulky fixtures, they often require surgery to mechani-
cally increase their airway volume [5].
Studies have described factors associated with the presentation and severity 
of OSA. Conditions that narrow the upper airway are particularly injurious to the 
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at-risk patient. Physiologic features such as obesity (which increases the mass of the 
soft tissues around the neck), decreases in muscle or neural tone (which frequently 
results from sedation or old age), congenital gnathic hypoplasias (which may exist 
without other notable medical findings), and craniofacial syndromes (which could 
contribute to abnormal hypoplasia of multiple craniofacial features) have been 
implicated [6].
2. History
Ancient Greeks first noted OSA or OSA-like snoring conditions in their 4th 
century BC accounts of Dionysius, the tyrant of Heraclea who was said to be “obese 
beyond measure.” The first modern medical description is attributed to James 
Russell and his peers as a syndrome of obesity and daytime drowsiness. OSA was 
poetically if not erroneously named the “Pickwickian syndrome” after the snoring 
“fat boy Joe” in Charles Dickens’s novel “The Posthumous Papers of the Pickwick 
Club.” [7] Dickens’s tale would depict the life of an obese servant boy whose day-
time activities were marred by debilitating drowsiness as often noted in modern 
OSA patients.
While clinicians and writers alike noted the distinct obesity of most OSA 
patients, obstruction was deemed inevitable until the development of the CPAP 
device in 1981 by Colin Sullivan and colleagues at the University of Sydney [8]. 
CPAP first saw use as a bulky nasal device that soon became the gold standard in 
OSA care.
3. Causes
OSA frequently co-presents with chronic conditions, the most prevalent of 
which is obesity. Obesity increases the mass and volume of parapharyngeal tissues, 
which can fall back in a supine position to cause respiratory obstruction during 
sleep. In fact, supine sleepers and patients with adeno-tonsillar enlargements 
experience OSA more frequently [9]. Metabolic conditions like hyperlipidemia and 
diabetes that may result from one or both of OSA and obesity [10].
Similarly, other pathoses leading to airway narrowing also predispose patients 
to OSA. Central and peripheral neural injuries that decrease the airway muscle 
tone have been shown to contribute to OSA in patients suffering from trauma [11]. 
Craniofacial syndromes like Down Syndrome that cause retrolingual hyperplasia 
and/or mandibular hypoplasia have been implicated in higher instances of OSA [6]. 
As such, OSA may also entail a genetic component with shared genes involving the 
formation of the nose, mouth, and throat likely predisposing certain families to 
higher rates of disease.
4. Signs and symptoms
As noted above, OSA has historically been defined by daytime drowsiness, loud 
snoring, and nighttime choking. This frequently leads to a higher incidence of 
automotive accidents and narcolepsy-like episodes [4]. Furthermore, implications 
in neurocognitive pathoses including impairments to attention, executive function-
ing, and long-term memory have been documented [12].
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More recent studies indicate that OSA may also be an etiological factor behind 
diabetes, hypertension, coronary artery disease, and stroke. Appropriate treatment of 
OSA may reduce the risk of developing these conditions [10]. Obesity may also play a 
role as both a risk factor and a complication of OSA. Studies stipulate that alterations 
of molecular signaling pathways via repeated hypoxic episodes contribute to auto-
nomic dysregulation, systemic inflammation, cardiopulmonary irregularities, and 
organic oxidation which predispose patients to metabolic diseases [13]. In fact, OSA 
has been linked to an increased risk of early death in patients under the age of 70 [2].
Studies of OSA in children are less common and may be confounded by the 
effects of puberty. They nonetheless indicate that while children with sleep-
disordered breathing are at risk of attention and executive deficits like their adult 
counterparts, they show additional deficits in empathy, social behaviors, and 
phonological processing [12]. Children with OSA may also be predisposed to 
pulmonary hypertension and nocturnal enuresis [14].
5. Diagnosis
Today, polysomnography plays a central role in the diagnosis of both central and 
obstructive sleep apnea. A patient’s apnea-hypopnea index (AHI) is taken along with 
the patient’s brain (electroencephalography or EEG), eye (electrooculography or 
EOG), muscle (electromyography or EMG), and/or heart (electrocardiography or 
ECG) activities which enumerates the average number of apneic or hypopneic events 
per hour of physiologic sleep. An apneic event is defined as a 90% or more reduction 
of airflow lasting at least 10 seconds. An hypopneic event is defined as a 30–90% 
reduction of airflow lasting at least 10 seconds accompanied by a 3% or greater 
decrease in pulse oxygenation [15]. A diagnosis of mild OSA is made with an AHI of 
5 to 15, moderate OSA with AHI of 15 to 30, and severe OSA with AHI of 30 or more 
events per hour (Table 1). Significant ECG abnormalities may also be present, which 
could indicate an increased severity of disease [13]. This scale is adjusted for the cat-
egorization of OSA in children. Pediatric OSA is classified as mild if AHI is between 
1 to 5, moderate if between 5 to 10, and severe if greater than 10 events per hour.
Though less common, some literature instead utilize the respiratory disturbance 
index (RDI) to diagnose or monitor the progress of OSA. The RDI is determined as 
a sum of AHI and respiratory-effort related arousals (RERAs), which are character-
ized by increasing respiratory effort for 10 seconds or more leading to an arousal 
from sleep. Similarly to the AHI scale, the American Academy of Sleep Medicine 
regards RDI of 5 to 15 as mild, 15 to 30 as moderate, and more than 30 as severe [16].
Drug-induced sleep endoscopy (DISE) is another diagnostic modality for the 
detection of upper airway collapse during sleep. A sedative agent such as propofol, 
AHI or RDI OSA Severity
Less than 5 None
5 to 14 Mild
15 to 29 Moderate
More than 30 Severe
Table 1. 
AHI and RDI scales [13, 15, 16].
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How likely are you to doze off or fall asleep in the following scenarios?
0 = Never
1 = Slight chance of dozing off
2 = Moderate chance of dozing off
3 = High chance of dozing off
Total Score – A score of greater than 10 denotes a higher risk of OSA
0 – 5: Lower normal daytime sleepiness
6 – 10: Higher normal daytime sleepiness
11 – 12: Mild excessive daytime sleepiness
13 – 15: Moderate excessive daytime sleepiness
16 – 24: Severe excessive daytime sleepiness
Scenario       Score
Sitting and reading      ________
Watching TV      ________
Sitting inactive in a public place (i.e. theater)    ________
As a passenger in a car for an hour    ________
Lying down to rest in the afternoon    ________
Sitting and talking to someone     ________
Sitting quietly after lunch without alcohol    ________
While stopped in traffic for a few minutes    ________
Table 2. 
Epworth Sleepiness Scale [18].
Item 1: if “Yes,” a point is added.
Item 2: if “c” or “d,” a point is added
Item 3: if “a” or “b,” a point is added
Item 4: if “a,” a point is added
Item 5: if “a” or “b,” two points are added.
Category 1 is “positive” if the total points above are 2 or higher.
Item 6: if “a” or “b,” a point is added
Item 7: if “a” or “b,” a point is added
Item 8: if “a,” a point is added
Category 2 is “positive” if the total points above are 2 or higher.
Category 3 is “positive” if the answer to item 10 is “Yes” or if the patient BMI is greater than 30kg/m∧2
Patients are considered high risk of 2 or more categories are deemed positive.
Item 1: Do you snore? Item 6: How often do you feel tired or 
fatigued after sleep?
 A. Yes  A. Nearly every day
 B. No  B. 3-4 times per week
 C. Do not know  C. 1-2 times per week
 D. 1-2 times per month
 E. Never or nearly never
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midazolam, or dexmedetomidine is administered to create a somewhat artificial 
state of sleep, during which a flexible endoscope is utilized to view the nasopharyn-
geal and oropharyngeal airways to monitor areas of collapse. While DISE can be a 
useful modality in detecting the degree and pattern of obstruction, its use may be 
limited as a result of 1) unnatural sleep patterns as a result of drug-induced nature 
of the slumber, 2) difficulty of maintaining the appropriate degree of sedation 
without causing undue cessation of respiration, and 3) uncertain reproducibility 
when scoring the degree of obstruction across different observers [17]. The use of 
propofol and/or dexmedetomidine purportedly re-creates a more natural pattern of 
sleep when compared to other medications like benzodiazepines.
The clinical manifestation of daytime sleepiness can be monitored via several 
patient surveys such as the Berlin and Epworth Sleepiness questionnaires  
(Tables 2 and 3). Recent studies suggest that the STOP-BANG questionnaire  
(Table 4) as devised by researchers at the University of Toronto is particularly 
effective not only as a screening tool but also as an adjunct to clinical follow up after 
operative interventions [21, 22].
Item 2: Your snoring is Item 7: During your waking time, do you 
feel tired or fatigued?
 A. Slightly louder than breathing.  A. Nearly every day
 B. As loud as talking  B. 3-4 times per week
 C. Louder than talking  C. 1-2 times per week
 D. Can be heard in adjacent rooms  D. 1-2 times per month
 E. I do not snore  E. Never or nearly never
Item 3: How often do you snore? Item 8: Have you ever nodded off or fallen 
asleep while driving a vehicle?
 A. Nearly every day  A. Yes
 B. 3-4 times per week  B. No
 C. 1-2 times per week
 D. 1-2 times per month
 E. Never or nearly never
Item 4: Has your snoring ever bothered other people? Item 9: How often do you nod off while 
driving?
 A. Yes  A. Nearly every day
 B. No  B. 3-4 times per week
 C. Do not know  C. 1-2 times per week
 D. 1-2 times per month
 E. Never or nearly never
Item 5: Has anyone noticed that you stop breathing during 
sleep?
Item 10: Do you have high blood pressure?
 A. Nearly every day  A. Yes
 B. 3-4 times per week  B. No
 C. 1-2 times per week  C. Do not know
 D. 1-2 times per month
 E. Never or nearly never
Table 3. 
Berlin Questionnaire [19].
Surgical Management of Head and Neck Pathologies
6
In general, patients with a score of 2 or below are considered low risk, 3 to 4 
intermediate risk, and 5 or greater high risk.
6. Management
Treatment of OSA may frequently reverse its systemic consequences, though 
permanent brain alterations may occur that prevent complete recovery of deficits 
in psychomotor functioning [12]. However, most studies concur that metabolic 
consequences (including those associated with diabetes and obesity) improve after 
resolution or improvement of OSA [4, 6, 12].
An effective management of OSA can be categorized as either a “success” or a 
“cure.” In general, a successful treatment denotes a 50% or greater reduction in AHI 
such that it decreases to an AHI of 20 events per hour or less. The definition of a 
curative treatment is more stringent and requires the reduction of AHI to 5 events s 
per hour or less [13]. Interventional success may also be defined as a 50% or greater 
reduction in RDI with a post-procedural RDI of 15 or less [23].
7. Conservative management
Conservative therapy remains the mainstay of OSA treatment because of their 
low risk and reversibility of treatment. Furthermore, pharmacologic and/or surgical 
interventions may require a stricter set of inclusion criteria and may not be appro-
priate for every patient [24].
Conservative therapy can be as non-invasive as a simple avoidance of certain 
substances or dietary patterns. As described previously, avoidance of obesity via 
healthy diet and possibly even exercise alone may improve symptoms of OSA 
[25]. Abstinence from sedating compounds and airway muscle relaxants – such as 
alcohol - is also beneficial [26]. Patients should cease exposure to airway irritants 
like tobacco smoke and partake in activities that encourage patency of the airway 
like sleeping in inclined or lateral positions and playing wind instruments [26–29].
CPAP devices are considered the gold standard of OSA therapy. They func-
tion by creating consistent air pressures in airways to keep them patent during 
sleep. CPAP has a long history of demonstrated efficacy, and its use has also been 
A point is added for each question that is answered with a “yes.”
Snoring: Do you snore loudly?
Tired: Do you often feel tired, fatigued, or sleepy during the daytime?
Observed choking: Has anyone observed you choking during sleep?
Pressure: Do you have or are being treated for high blood pressure?
Body mass index: Is your BMI more than 35kg/m∧2?
Age: Are you older than 50 years of age?
Neck size: Is your shirt collar size >17 in for males or >16 in for females?
Gender: Are you biologically male?
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associated with decreases in a number of associated conditions including cogni-
tive impairment, daytime drowsiness, and cardiovascular disease [30–32]. CPAP 
machines are nonetheless bulky and uncomfortable to wear, leading to a high rate of 
noncompliance [33]. Modified equipment such as bilevel positive airway pressure 
(BiPAP) or automatically-titrated (APAP) devices, which monitors breathing to 
exert a higher pressure during inhalation and a lower pressure during exhalation, 
can reduce discomfort associated with their use [34].
Oral appliance therapy is also considered an acceptable, reversible therapy for 
OSA especially in cases of mild or moderate sleep apnea [35]. The devices typi-
cally function by inducing an anterior posture of the mandible that, in theory, 
helps increase the antero-posterior diameter of the retrolingual airway. While oral 
appliances are much more compact and often better tolerated, its efficacy remains 
controversial and long term use may be associated with dry mouth, dental trauma, 
and jaw pain [26, 36].
8. Pharmacologic interventions
In general, the evidence supporting pharmacotherapy remains insufficient.  
[24, 37] Antidepressants and serotonin-promoting compounds were studied 
because activation of serotonin 5-HT2 receptors in the brainstem was shown to 
induce excitatory input to the hypoglossal neurons, which in turn incites an anterior 
advancement of the tongue [38]. Mirtazapine in particular was shown to reduce 
AHI in the short term, but its long-term administration is associated with sedation 
and weight gain, which are known adverse risk factors of worsening OSA [39]. 
Paroxetine was also studied but its effects were found not to be significant, [40] 
possibly because non-discriminatory activation of both peripheral 5-HT3 and 5-HT2 
and receptors has been associated with REM-associated apnea [41].
Parasympathomimetics like donepezil may modulate airway and/or tongue 
muscle contraction via cholinergic pathways. Its use was associated with a reduction 
in AHI by approximately 20%, [42] which would not meet the clinical definition 
of successful or curative treatment in all but mild cases. Respiratory smooth-
muscle relaxants like theophylline were found to be either ineffective or to trigger 
counter-productive deteriorations in sleep quality because of their stimulatory 
 properties [43].
Dronabinol and a combination of ondansetron and fluoxetine demonstrated 
some promise in controlling the rate of AHI in sleep apneic patients. While 
ondansetron or fluoxetine alone were ineffective, their combination showed 
more than a 40% reduction in AHI. Investigators stipulate that fluoxetine may 
stimulate central 5-HT2 receptors while ondansetron suppresses the activation 
of their peripheral 5-HT3 counterparts [44]. Dronabinol also incurred dose-
dependent 40–50% reductions in AHI over a 6-week period of use. Cannabinoids 
like dronabinol activates cannabinoid type 1 (CB1) receptors, which in turn also 
antagonizes the actions of 5-HT3 receptors [45]. However, neither the ondanse-
tron-fluoxetine combination nor dronabinol showed clear clinical improvements 
in daytime drowsiness.
9. Sleep surgery
While conservative therapy is considered the first line intervention for OSA, 
surgery may be indicated in patients who are unable or unwilling to tolerate lifelong 
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conservative therapy [5]. A 2004 study of military veterans suggested that even 
singular surgical therapy may provide more than a 30% increase in overall survival 
benefit [46]. In fact, a combination of multiple surgical modalities may achieve a 
60% reduction in AHI, which is comparable to that of CPAP which demonstrates 
between a 60 to 70% reduction [47, 48].
10. Tonsillectomy
Surgical intervention may encompass the soft and/or the hard tissues of the 
upper airway. Tonsillectomy is a soft tissue-oriented procedure that may be of 
benefit especially in children since their apneic episodes are predominantly caused 
by enlarged lymphoid tissues of the upper airway [3]. The long-term efficacy, 
however, is not yet well established [49]. In tonsillectomy, the lymphoid tissues 
and its capsular container are dissected wholly from its surrounding tissues. Sharp 
dissection with scalpel and electro- or diathermic-cautery may be used, followed 
by blunt dissection [50]. Notable vessels in the area are ligated using sutures which 
may be assisted by using topical thrombin. Post-operative bleeding may be signifi-
cant which manifests in approximately 2% of patients and typically occurs approxi-
mately 1 to 2 weeks post-operatively [51].
11. Septoplasty with or without turbinate reduction
Septoplasty may also be conducted to address obstructions of the nasal pas-
sageway, which could worsen OSA symptoms. It is frequently conducted in patients 
with or without OSA to help relieve internal nasal valve obstruction. While nasal 
surgery alone may not significantly reduce AHI, it may be a viable adjunct therapy 
when utilized with another intervention [52]. Septoplasty with turbinate reduction 
has been associated with better tolerance of CPAP therapy [53].
To conduct septoplasty, an intranasal vertical incision is made through the 
septal mucosa and the perichondrium on the side of the obstruction (Figure 1). 
The approach is then taken posteriorly in a sub-perichondral fashion using a blunt 
instrument. The overlying soft tissues are carefully dissected from the obstructing 
spur or deviation to avoid tears. Vertical chondrotomies are made anterior and pos-
terior to the obstruction so that the mucosa may be detached from the contralateral 
septal surface. A horziontal chodrontomy is made connecting the superior edges of 
the vertical chondrotomies. The horizontal chondrotomy is made at least 1 cm from 
the superior margin of the septum to preserve the structural integrity of the septum 
and prevent a saddle defect. The portion of cartilage containing the spur or devia-
tion is then freed from the nasal spine and removed.
Adjunctive turbinate reduction may be accomplished via another vertical, full-
thickness incision anterior to the inferior turbinate (or concha) at the attachment 
point to the lateral nasal wall (Figure 2). A subperiosteal plane is raised to expose 
the osseous turbinate. Forceps may then be introduced through the incision to 
remove the turbinate in small pieces. The overlying mucosa should also be reduced 
using a microdebrider without perforating through the soft tissue. Any remaining 
osseous portions may then be outfractured with a blunt instrument by applying 
lateral pressure.
The septal and/or turbinate mucosal incisions are sutured closed using a resorb-
able suture. Doyle splints or multiple interrupted transseptal sutures may be placed 
for five days to prevent the formation of a septal hematoma.
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12. Uvulopalatopharyngoplasty
Uvulopalatopharyngoplasty (UPPP) is perhaps the most performed sleep 
surgery. While the large variety of OSA-associated factors make it difficult to gauge 
the exact success rate of UPPP, it appears to be more efficacious in patients without 
excessive neck size or BMI. UPPP is also notably less effective in those with multi-




Inferior turbinate position in the nasal cavity.
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In UPPP, the uvula, tonsils, and sometimes adenoids are first removed to remove 
the protrusive bulks of oropharyngeal tissue with particular attention towards 
preserving the posterior tonsillar pillars (Figure 3). The uvula may be excised with 
a wedge incision through its base to aid in closure.
The operator could then elect to further widen the lateral soft tissues of the 
oropharynx via lateral expansion pharyngoplasty. The bilateral palatopharyngeus 
muscles are located through the tonsillectomy incisions, dissected from the pha-
ryngeal walls, then transected at a point approximately 2/3rds of the way from the 
palate to the tonsillar pillar base. The freed muscles may then be folded antero-
superiorly through a tunnel deep to the palatal mucosa or through an incision placed 
through the palatal soft tissues. The previously transected edge of the palatopha-
ryngeus is then sutured to the fixed aponeurotic tissues around the hamulis such 
that the action of the palatopharyngeus triggers a lateral expansion of the airway at 
the soft palate.
The posterior palatal pillars may then be suspended anteriorly via suturing the 
pillars to the pterygomandibular raphe. The incision sites for the uvula, tonsils, 
adenoids, and/or palatopharyngeus are sutured closed to create a smooth mucosal 
surface.
13. Hyoid suspension
Hyoid suspension (HS) is a relatively noninvasive surgical procedure that is 
commonly performed in conjunction with UPPP or genioglossus advancement. 
Like UPPP, HS is indicated for milder cases of OSA with retrolingual and hypopha-
ryngeal (not retropalatal) obstructions [55]. HS alone may not provide significant 
Figure 3. 
An anatomic depiction of the uvula, tonsils, and their surrounding pillars.
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improvements to the AHI and is typically conducted as a component of compre-
hensive therapy [23]. In a study of female OSA patients, isolated HS consistently 
failed to achieve surgical success but obtained near-curative results when hyoid-
mandibular suspension was conducted alongside UPPP [55].
HS functions via an artificial anteropositioning of the hyoid and thus increased 
anteroposterior dimensions of the airway [23]. The hyoid bone would traditionally 
be suspended to the lingual surface of the mandible, (Figure 4) though the need 
for an additional incision at the submental region as well as extensive dissection 
through the submental tissues have led to modified procedures that suspend the 
hyoid bone to the thyroid cartilage instead [55].
Figure 4. 
Position of the hyoid bone.
Figure 5. 
The muscular and ligamentous attachment sites of the hyoid bone.
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In both surgical variants, the hyoid bone is first approached via a direct incision. 
The infra-hyoid muscles are dissected from the bony surface and the stylohyoid 
ligaments are sectioned from the lesser cornu (Figure 5). In cases of hyoid suspen-
sion to the mandible, the submental region is then approached via sharp and/or 
blunt dissection to the lingual surface of the mandible. The digastric and mylohyoid 
muscles are separated laterally to avoid complete dissection from the mandible.
Two or more bony anchors are placed near the attachment site of the genioglos-
sus (Figure 6). Non-resorbable sutures or wires may be wrapped around the body 
of the hyoid then passed through the bony anchors (in the case of hyo-mandibular 
suspension) or the thyroid cartilage (in the case of hyo-thyroid suspension) to 
advance the hyoid bone approximately 3 cm, inducing tension in its muscular 
attachments [23, 55]. A drain may left in place for 2 to 3 days to help reduce the risk 
of seroma or hematoma.
14. Genioglossus advancement
Genioglossus advancement (GA) is another surgical procedure commonly 
conducted in combination with HS or maxillomandibular advancement. The genio-
glossus muscle - and therefore, the base of the tongue – is advanced anteriorly to 
increase the anteroposterior diameter of the retrolingual airway [56]. While its rate 
of success as a standalone treatment remains at approximately 50%, this rate may 
increase greatly when conducted in conjunction with maxillomandibular advance-
ment [57]. As expected, GA is not effective in treating obstructions at the palate.
GA may be performed as an anterior mandibular osteotomy to advance the 
genioglossus muscle without altering the external appearance of the chin. A pre-
operative CT scan is utilized to locate the anterior attachment site of the genioglos-
sus at the mental spine of the mandible (Figure 7). An osteotomy guide – frequently 
made as an occlusal-based appliance to fit over the mandibular dentition - is then 
created to separate this site from the rest of the mandible via a rectangular bicortical 
osteotomy approached from the buccal side of the mandible [56].
An intraoral incision is made through the anterior mandibular buccal vestibule 
to reach the osteotomy site at the symphysis. The subperiosteal dissection should be 
extended down to the inferior border of the mandible and laterally to the regions of 
the bilateral canines. Once the osteotomy is conducted, the freed segment of man-
dibular bone is typically advanced such that the lingual cortex of the freed segment 
is at or anterior to the buccal cortex of the surrounding mandible. The buccal cortex 
and the cancellous portions of the freed segment may be trimmed away to minimize 
Figure 6. 
Depiction of the genioglossus and its attachment site.
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bony protrustion at the chin. The freed segment is fixated in place using titanium 
plates, which may be custom-made for convenience.
GA may also be performed as a part of cosmetically driven genioplasty in indi-
viduals with retrognathia. A large portion of the mental protuberance is advanced 
in addition to the segment of bone attached to the genioglossus muscle, which 
increases chin volume and esthetic outcome [57]. Instead of osteotomizing just the 
attachment site of the genioglossus, the operators would utilize an osteotomy guide 
that also encompasses a bulk of the mental protuberance (Figure 8).
15. Maxillomandibular advancement
Maxillomandibular advancement (MMA) is considered an effective surgical 
modality for patients affected by nasopharyngeal, retropalatal and/or retrolingual 
obstructions [5, 58, 59]. A recent meta-analysis suggests that MMA has greater than 
a 98% rate of clinical improvement, 85% rate of treatment success, and approxi-
mately 40% rate of a complete cure [59]. A potential downside of MMA treatment 
includes its invasiveness and applicability only in individuals who are esthetically 
amenable to an increasing prominence of the bimaxillary complex. Conversely, 
an MMA may be especially well suited for patients with hypoplastic dentofacial 
deformities who require such bony changes [60].
Figure 7. 
Mental spine and the attachment sites of the genioglossus muscle.
Figure 8. 
Mental protuberance at the inferior aspect of the mandibular symphysis.
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Like GA, MMA requires pre-operative planning frequently aided by CT scans. 
The radiographs may then be supplemented by stone models or optical scans of 
the patient’s dentition to increase the accuracy in virtual surgical planning (VSP). 
Occlusal dental splints are produced which help execute the planned bony move-
ments. MMA also frequently requires that approximately 1 year of pre-operative 
orthodontics be conducted to create a stable occlusion that is not only esthetic but is 
amenable to intermaxillary fixation (IMF).
To conduct MMA, a LeFort 1 osteotomy and a bilateral sagittal splint osteotomy 
(BSSO) are conducted to advance the palatal-alveolar complex and the body of the 
mandible, respectively (Figure 9). These horizontal advancements may be con-
ducted in conjunction with a counterclockwise rotation of the maxillomandibular 
Figure 9. 
The palatal-alveolar complex of the maxilla.
Figure 10. 
The anterior, medial, lateral, and posterior walls of the maxillary sinus and their relationships to the lateral 
pterygoid plate.
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complex (when viewed in a right lateral position) to accomplish a total advancement 
of the mandibular symphysis by at least 10 mm from its native position [57, 60].
Typically, the LeFort 1 osteotomy is conducted first to establish a stable upper 
dental position. The anterior and lateral walls of the maxilla are exposed via an 
incision through the maxillary buccal vestibule. A subperiosteal dissection is con-
ducted, after which a saw osteotomy is made through the anterior and anterolateral 
walls of the maxillary sinuses (Figure 10). The osteotomies are continued poste-
riorly through the medial and lateral walls of the sinuses using osteotomes. The 
lateral pterygoid plates are also detached from the maxilla proper using a curved 
osteotome. The operator may elect to make a lateral approach to the pterygoid plates 
by gently “walking” the osteotome posteriorly along the lateral and posterior walls 
of the maxillary sinuses until the tip of the osteotome makes contact with a slight 
concavity at the pterygomaxillary junction. Gentle mallet impacts are then utilized 
to accomplish the detachment.
The nasal mucosae are also bluntly dissected from its attachments to the inferior 
and lateral walls of the nasal cavity. At this point, the posterior walls of the maxil-
lary sinuses are the only osseous connections between the palatal-alveolar and 
the midface segments of the maxilla (Figure 11). A gentle downward pressure is 
applied at the anterior maxillary dentition to cause a controlled, horizontal fracture 
across the posterior walls of the maxillary sinuses. The soft tissue attachments 
to the palatal-alveolar segment are then stretched in preparation for its anterior 
movement.
The freed palatal-alveolar segment is then advanced approximately 10 mm via 
the use of preformed “intermediate” dental occlusal splints, which engages the 
mandibular dentition to hold the maxillary teeth approximately 10 mm anteriorly 
from their original positions. IMF is conducted with the splint in place (either 
with arch bars, pre-existing orthodontia, or intermaxillary screws) to stabilize the 
palatal-alveolar segment to the mandible. This allows the surgeons to trim and apply 
plate fixation to the palatal-alveolar segment in its new position relative to the rest 
of the maxilla.
The BSSO is performed next, although some providers may elect to perform the 
BSSO first followed by the LeFort 1 osteotomy. IMF is released and incisions are 
made through the bilateral buccal vestibules of the mandible to reveal the lateral 
Figure 11. 
A coronal section demonstrating the darkened, intact posterior walls of the maxillary sinuses.
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cortex of the mandibular body as well as the antero-medial surfaces of the ramus. A 
monocortical saw osteotomy is then started from a point just superior to the lingula 
and continued downwards along the superolateral cortex of the mandibular body 
until it reaches the cortex just lateral to the first molar (Figure 12). The positioning 
of this osteotomy reduces the risk of injury to the inferior alveolar neurovascular 
bundle at its entrance and through its canal. Gentle osteotome pressure is applied 
through the osteotomies to propagate controlled fractures at the posterior wall of 
each ramus and the inferior wall of each mandibular body.
Once the body of the mandible is freed from its bilateral ramus-condyle seg-
ments, preformed “final’ dental occlusal splint may be used to advance the mandib-
ular body segment. The splint engages the now-stable maxillary dentition to hold 
the mandibular teeth approximately 10 mm anteriorly from their original positions. 
IMF is again conducted with the new splint in place. The mandibular segment may 
be fixated in its new position (using orthopedic plates) relative to the bilateral 
ramus-condyle segments. After releasing the IMF and confirming correct occlu-
sion, the patient should be re-placed in IMF for approximately two weeks followed 
by four additional weeks of non-chew diet.
The BSSO should be conducted first in cases where the pre-operative CT scans 
were taken without the condylar heads seated in the temporal fossa. The condyles 
may be seated after a proper mandibular advancement, and the new mandibular 
dental occlusion may then be used as the reference against which the palatal-alveo-
lar segment is advanced.
16. Hypoglossal nerve stimulator
The hypoglossal nerve stimulator (HGNS) is a newly developed device that acti-
vates the hypoglossal nerve upon detection of an apneic episode. It includes a sensing 
and a stimulating electrode, which detects then mitigates apnea, respectively. HGNS 
is particularly effective in individuals with non-concentric, antero-posterior collapse 
of the retrolingual airway on DISE. It demonstrated a median AHI improvement of 
68% in individuals with BMIs under 32 kg/m^2 [61]. After implantation, the HGNS 
impulses may be adjusted according to the patient’s post-operative AHI and/or RDI 
Figure 12. 
The maxillomandibular complex. BSSO are conducted through the superolateral cortex of the mandibular 
body just medial to the ramus and just lateral to the posterior dention.
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values. Higher impulse charges may be avoided in sensitive individuals who are 
awakened by a sudden activation of the hypoglossal nerve.
To place the HGNS, a submandibular incision is first made approximately 2 cm 
below the inferior border of the mandible to avoid the marginal mandibular branch 
of the facial nerve. The site is dissected until the hyoid bone is appreciated, fol-
lowed by a slight lateral extension to identify the posterior and anterior bellies of the 
digastric muscle (Figure 13). The digastric tendon is identified and isolated from the 
surrounding soft tissues using retractors. The hypoglossal nerve is found in the space 
medial to the digastric muscle just lateral to the hyoid bone. It is close to the Ranine 
vein which lies immediately posterior.
The Ranine vein may be ligated and the hypoglossal nerve further dissected 
anteriorly from the surrounding tissues to locate its “inclusion” and “exclusion” 
branches. The inclusion branches are those that protrude the tongue and the exclu-
sion branches are those that retrude it. The two branches may be distinguished with 
a stimulator, and the HGNS stimulating electrode is cuffed to the primary inclusion 
branch. The electrode itself should be secured to the digastric tendon using nonre-
sorbable sutures to prevent dislocation from the nerve.
The upper chest incision is then made approximately 4 cm below the mid- 
clavicle down to the pectoralis fascia, which is left intact. A supra-fascial dissection 
is made to create a small cavity for the pulse generator. A lateral chest incision is 
also needed about 2 cm below and 5 cm laterally from the nipple for the implanta-
tion of the sensing lead. The approach is continued through the serratus anterior 
and external intercostal muscles to secure the sensing electrode in a plane between 
the external and internal intercostal muscles (Figure 14). The internal intercostal 
muscles must be left intact to avoid pneumothorax.
Figure 13. 
Main anatomic landmarks for HGNS surgery including the hyoid bone and the digastric muscles.
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The sensing electrode wires are tunneled subcutaneously from the lateral chest 
site to the pulse generator at the upper chest site. Similarly, the stimulating elec-
trode wires are also tunneled in a sub-platysmal plate from the neck site to the pulse 
generator. The pulse generator is sutured in place at the upper chest pocket and 
connected to the respective electrode wires. The generator’s power supply should be 
replaced approximately every ten years.
16.1 Tracheostomy
Tracheostomy is perhaps the oldest and the most definitive intervention for 
OSA. An incision is made through the anterior neck to insert a semi-permanent air-
way, bypassing both the naso- and oropharynx. Though it is typically performed to 
establish an emergency airway and/or to create a long-term ventilation port, it may 
be performed in cases of severe obstructive sleep apnea that is otherwise refrac-
tory to other treatment modalities. Tracheostomy is considered a treatment of last 
resort owing to its invasive nature and a relatively high rate of complications such as 
hemorrhage, tracheal stenosis, tracheoesophageal or tracheocutaneous fistula, and 
bronchospasm regardless of the approach taken [62, 63]. A recent systematic review 
indicated that percutaneous dilatational tracheostomy carries an overall mortality 
rate of approximately 1 in 600 [64]. It also requires dedicated maintenance includ-
ing frequent suctioning and regular replacement of its parts.
Elective tracheostomy for OSA should be conducted in a sterile fashion in the 
operating room. A horizontal incision is made approximately 2 cm superior to the 
Figure 14. 
The external and internal intercostal muscles.
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suprasternal notch then dissected through the subcutaneous and platysmal lay-
ers. The subsequent fascia and strap muscles are divided along a vertical line until 
the thyroid gland or the pretracheal fascia are encountered. Any thyroid tissues 
encountered may be retracted superiorly, and the pretracheal fascia bluntedly dis-
sected away from the airway.
At this point, the patient’s FiO2 should be lowered and the endotracheal tube 
advanced further to avoid the risk of fire and cuff puncture, respectively. A 
horizontal incision is first made between the tracheal rings (Figure 15). This is 
connected to a vertical, downward incision through the tracheal ring just below 
from each end of the horizontal incision to raise a Bjork flap. Resorbable sutures 
are passed under the cartilagenous ring to fixate the flap to the overlying skin. An 
appropriately sized tracheostomy tube is inserted atraumatically then stabilized to 
the neck using a trap. The endotracheal tube may be removed, and the tracheos-
tomy tube cuff inflated.
17. Pediatric OSA
In general, both the prevalence and treatment threshold for OSA in children 
is lower [65]. Children with AHI greater than 5 should undergo treatment to help 
normalize breathing. For patients with AHI ranging from 1 to 5, treatment should 
be considered if OSA-related comorbidities such as obesity, hyperactive behaviors, 
lymphoid hyperplasia, enuresis, and/or increased inflammatory markers are pres-
ent [65, 66]. Non-invasive measures like weight loss and avoidance of irritants like 
tobacco smoking are universally helpful [65].
Figure 15. 
The anatomy of the thyroid, cricoid, and tracheal cartilages.
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Most literature indicate an OSA incidence of 1 to 4% [67]. This occurrence 
peaks between the ages of 2 to 8, which roughly coincides with the peak instances 
of lymphoid hyperplasia. Traditional treatment therefore consists of tonsillectomy 
with or without adenoidectomy. However, the success rate may range as low as 27% 
even though delaying correction of disordered breathing can lead to gnathic or 
craniofacial anomalies [66]. While removal of tonsillar or adenoidal tissues can be 
conducted at any age, other surgical interventions may incur a greater rate of com-
plications (in non-syndromic patients) if conducted prior to age 3 or in individuals 
weighing less than 15 kg [65, 68].
Alternative surgical modalities include septoplasty and UPPP. Osseous surger-
ies should be reserved for those with craniofacial deficits as extensive osteotomies 
frequently disrupt the rate and pattern of skeletal growth. Maxillary and/or man-
dibular distraction may be employed early to utilize the rapid healing potential in 
children with severe micrognathia [65].
Unlike in adults, CPAP should be reserved for moderate or severe cases of pediat-
ric OSA that cannot be treated surgically [69]. CPAP compliance rate is even lower in 
children, and a lack of appropriate pediatric CPAP appliances as well as long sleep-
ing hours exacerbate this issue [70]. CPAP can also trigger nasal symptoms such as 
congestion, epistaxis, and midface retrusion [65]. Patients who cannot tolerate or are 
refractory to surgery and CPAP should undergo treatment via tracheostomy [69].
18. Surveillance
Post-intervention polysomnography or DISE may be conducted at least 3 months 
after therapy to reduce confounding effects of post-operative edema. STOP-BANG, 
Epworth, and/or Berlin questionnaires should also be utilized to ensure improve-
ments in the patient’s quality of life.
The Stanford Protocol is a predictable and effective protocol outlining the proper 
elevation of care in cases of OSA relapse [71]. Surgical management of OSA should 
begin with the phase 1 treatments consisting of septoplasty, UPPP, then GA. Phase 
2 treatment is MMA and may be conducted in case of relapse after phase 1. While 
phase 2 treatment appears sufficient for most patients, a recent update to the Protocol 
showed that HGNS could be conducted in cases of phase 2 treatment failure [72]. 
MMA may prevent lateral pharyngeal wall components of airway collapse, thereby 
increasing the efficacy of HGNS which best addresses antero-posterior obstructions.
19. Conclusions
Obstructive sleep apnea is a complex disease of numerous significant ramifica-
tions which require careful diagnosis and management. As with many chronic 
conditions, OSA should be first approached via conservative treatment which often 
remains equally or more effective as their invasive counterparts. Once the revers-
ible conservative modalities are exhausted, the more invasive therapies should be 
approached with caution. Modern interventional protocols like the Stanford Protocol 
may provide guidance based on the successes of large volume surgical cohorts.
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